ELTX vs PRU · $132.3M cap vs rev $31.19B
Elicio Therapeutics Inc. (ELTX) versus PRU (PRU) — a side-by-side from cached financials, not a winner call.
Elicio Therapeutics Inc. (ELTX) is a biotechnology company listed on US.
PRU (PRU) common stock.
ELTX does not have a complete income-statement cache yet.
Latest reported PRU revenue for 2026-06-30 was $31.19B. Net income was $1.58B. PRU currently screens at market cap $0.
ELTX currently screens at market cap $132.3M. PRU currently screens at market cap $0.
Not investment advice. Open the ELTX and PRU stock pages for the full models.
Not investment advice.